A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic Lupus Erythematosus.
作者信息
Garg Shivani, Plantinga Laura C
机构信息
S. Garg, MD, MS, Division of Rheumatology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin.
L.C. Plantinga, PhD, Divisions of Rheumatology and Nephrology, Department of Medicine, University of California, San Francisco, California, USA.
出版信息
J Rheumatol. 2024 Sep 1;51(9):841-844. doi: 10.3899/jrheum.2024-0654.
Abstract
摘要
相似文献
1
A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic Lupus Erythematosus.难以下咽的苦药：系统性红斑狼疮患者药物治疗依从性面临的挑战
J Rheumatol. 2024 Sep 1;51(9):841-844. doi: 10.3899/jrheum.2024-0654.
2
Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review.系统性红斑狼疮患者的药物治疗不依从性：一项系统评价
Arthritis Care Res (Hoboken). 2017 Nov;69(11):1706-1713. doi: 10.1002/acr.23191. Epub 2017 Sep 21.
3
Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus.实施以临床医生为主导的药物依从性干预措施，改善系统性红斑狼疮患者的治疗效果。
J Rheumatol. 2024 Sep 1;51(9):884-890. doi: 10.3899/jrheum.2024-0071.
4
Prevalence and associated factors of medication nonadherence among Thai patients with systemic lupus erythematosus.泰国系统性红斑狼疮患者药物治疗不依从的流行状况及其相关因素。
Lupus. 2021 Feb;30(2):352-359. doi: 10.1177/0961203320973072. Epub 2020 Nov 11.
5
Feasibility and Acceptability of a REDCap-Embedded HIPAA-Compliant Text Messaging Application to Track Medication Adherence in Adolescents With Lupus.一种嵌入REDCap且符合HIPAA标准的短信应用程序用于追踪狼疮青少年药物依从性的可行性和可接受性
J Clin Rheumatol. 2024 Dec 1;30(8):332-335. doi: 10.1097/RHU.0000000000002142. Epub 2024 Oct 1.
6
Depression and medication nonadherence in childhood-onset systemic lupus erythematosus.儿童期起病的系统性红斑狼疮中的抑郁与药物治疗不依从性
Lupus. 2018 Aug;27(9):1532-1541. doi: 10.1177/0961203318779710. Epub 2018 Jun 28.
7
Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population.系统性红斑狼疮（SLE）门诊患者的药物依从性障碍及不依从程度。
Rheumatol Int. 2021 Aug;41(8):1457-1464. doi: 10.1007/s00296-021-04898-0. Epub 2021 Jun 5.
8
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.环磷酰胺与甲泼尼龙治疗系统性红斑狼疮神经精神受累的比较
Cochrane Database Syst Rev. 2006 Apr 19(2):CD002265. doi: 10.1002/14651858.CD002265.pub2.
9
Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence.系统性红斑狼疮药物治疗不依从程度及其原因的特定评估工具的制定与初步验证。
J Rheumatol. 2022 Dec;49(12):1341-1348. doi: 10.3899/jrheum.220399. Epub 2022 Sep 1.
10
Frequency, barriers and facilitators of adherence to treatment among people with systemic lupus erythematosus in China: a scoping review.中国系统性红斑狼疮患者治疗依从性的频率、障碍及促进因素：一项范围综述
BMJ Open. 2025 Aug 19;15(8):e091845. doi: 10.1136/bmjopen-2024-091845.
本文引用的文献
1
Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus.实施以临床医生为主导的药物依从性干预措施，改善系统性红斑狼疮患者的治疗效果。
J Rheumatol. 2024 Sep 1;51(9):884-890. doi: 10.3899/jrheum.2024-0071.
2
Revolutionizing healthcare: the role of artificial intelligence in clinical practice.人工智能在临床实践中的应用：医疗保健的革命。
BMC Med Educ. 2023 Sep 22;23(1):689. doi: 10.1186/s12909-023-04698-z.
3
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards.澄清关于羟氯喹（HCQ）的误解：根据低健康素养标准制定 HCQ 获益与危害决策辅助工具（HCQ-SAFE）。
Lupus Sci Med. 2023 Jul;10(2). doi: 10.1136/lupus-2023-000935.
4
Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention development.患者和医疗团队推荐羟氯喹用药依从性策略：一项定性研究结果，为干预措施的制定提供了信息。
Lupus Sci Med. 2022 Aug;9(1). doi: 10.1136/lupus-2022-000720.
5
Drug monitoring in systemic lupus erythematosus.系统性红斑狼疮的药物监测。
Curr Opin Pharmacol. 2022 Jun;64:102225. doi: 10.1016/j.coph.2022.102225. Epub 2022 Apr 28.
6
Let's Talk About Lupus. Overview of an Innovative, High-Reach, Online Program to Fill the Education Gaps of Latin Americans Living With Lupus.让我们谈谈狼疮。一项创新的、高影响力的在线项目概述，旨在填补拉丁美洲狼疮患者的教育空白。
J Clin Rheumatol. 2022 Mar 1;28(2):e368-e374. doi: 10.1097/RHU.0000000000001728.
7
Implementing the DEcision-Aid for Lupus (IDEAL): study protocol of a multi-site implementation trial with observational, case study design : Implementing the DEcision-Aid for Lupus.实施狼疮决策辅助工具（IDEAL）：一项采用观察性案例研究设计的多中心实施试验的研究方案：实施狼疮决策辅助工具
Implement Sci Commun. 2021 Mar 11;2(1):30. doi: 10.1186/s43058-021-00118-9.
8
Barriers to Taking Medications for Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers, and Clinic Staff.系统性红斑狼疮患者服药障碍的定性研究：对少数族裔患者、狼疮提供者和临床工作人员的研究。
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1459-1467. doi: 10.1002/acr.24591. Epub 2022 Jun 1.
9
Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.监测系统性红斑狼疮患者羟氯喹水平的临床意义：系统评价和荟萃分析。
Arthritis Care Res (Hoboken). 2021 May;73(5):707-716. doi: 10.1002/acr.24155. Epub 2021 Mar 30.
10
Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy.羟氯喹血药浓度可预测羟氯喹视网膜病变。
Arthritis Rheumatol. 2020 Mar;72(3):448-453. doi: 10.1002/art.41121. Epub 2020 Jan 7.
Zotero 插件